Lucid Diagnostics

(NASDAQ) LUCD

Current Price$1.09

Market Cap$193.21M

Since IPO (2021)-91%

5 YearN/A

1 Year-16%

1 Month-5%

Lucid Diagnostics Financials at a Glance

Market Cap

$193.21M

Revenue (TTM)

$4.71M

Net Income (TTM)

$58.01M

EPS (TTM)

$-0.82

P/E Ratio

-1.32

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.09

Volume

4,448

Open

$1.10

Price

$1.09

Volume

4,448

Open

$1.10

Previous Close

$1.09

Daily Range

$1.09 - $1.12

52-Week Range

$0.95 - $1.70

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.09

Volume

4,448

Open

$1.10

Previous Close

$1.09

Daily Range

$1.09 - $1.12

52-Week Range

$0.95 - $1.70

LUCD News

LUCD Reports Results

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lucid Diagnostics

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Lishan Aklog, MD

Website

www.luciddx.com

Headquarters

New York City, NY 10165, US

LUCD Financials

Key Financial Metrics (TTM)

Gross Margin

-56%

Operating Margin

-11%

Net Income Margin

-12%

Return on Equity

-711%

Return on Capital

-4%

Return on Assets

-1%

Earnings Yield

-75.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$193.21M

Shares Outstanding

177.25M

Volume

4.45K

Avg. Volume

771.83K

Financials (TTM)

Gross Profit

$2.84M

Operating Income

$49.64M

EBITDA

$48.77M

Operating Cash Flow

$46.48B

Capital Expenditure

$197.00K

Free Cash Flow

$46.48B

Cash & ST Invst.

$34.70B

Total Debt

$25.82B

Lucid Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.50M

+25.6%

Gross Profit

$565.00K

+40.4%

Gross Margin

-37.57%

N/A

Market Cap

$193.21M

N/A

Market Cap/Employee

$2.68M

N/A

Employees

N/A

Net Income

$16.27M

-40.9%

EBITDA

$13.80M

-22.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$34.68B

+3141130.1%

Accounts Receivable

$643.00K

+58.8%

Inventory

$353.00M

+103419.1%

Long Term Debt

$927.00K

-48.5%

Short Term Debt

$24.89M

+28.0%

Return on Assets

-1.43%

N/A

Return on Invested Capital

-4.18%

N/A

Free Cash Flow

$12.63M

-24.7%

Operating Cash Flow

$12.58M

-27.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVRAnteris Technologies Global Corp.

AVRAnteris Technologies Global Corp.$6.06-4.79%

APYXApyx Medical Corporation

APYXApyx Medical Corporation$2.89-5.56%

RPIDRapid Micro Biosystems, Inc.

RPIDRapid Micro Biosystems, Inc.$2.50-1.03%

SEERSeer, Inc.

SEERSeer, Inc.$1.98-2.46%

RCELAVITA Medical, Inc.

RCELAVITA Medical, Inc.$4.35-2.03%

SCLXScilex Holding Company

SCLXScilex Holding Company$11.20+5.86%

OWLTOwlet, Inc.

OWLTOwlet, Inc.$4.84-0.21%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.48+2.67%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.21+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.74+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.65+0.03%

PNSkycorp Solar Group

PNSkycorp Solar Group$5.53+0.93%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.09-0.09%

ADTADT

ADTADT$7.08-0.06%

Questions About LUCD

What is the current price of Lucid Diagnostics?

Lucid Diagnostics is trading at $1.10 per share.

What is the 52-week range for Lucid Diagnostics?

Over the past 52 weeks, Lucid Diagnostics has traded between $0.95 and $1.70.

How much debt does Lucid Diagnostics have?

As of the most recent reporting period, Lucid Diagnostics reported total debt of $25.82M.

How much cash does Lucid Diagnostics have on hand?

Lucid Diagnostics reported $34.70M in cash and cash equivalents in its most recent financial results.

What is Lucid Diagnostics’s dividend yield?

Lucid Diagnostics does not currently have a dividend yield.

Lucid Diagnostics

Lucid Diagnostics Financials at a Glance

LUCD News

LUCD Reports Results

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lucid Diagnostics

LUCD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lucid Diagnostics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LUCD

What is the current price of Lucid Diagnostics?

What is the 52-week range for Lucid Diagnostics?

How much debt does Lucid Diagnostics have?

How much cash does Lucid Diagnostics have on hand?

What is Lucid Diagnostics’s dividend yield?

Premium Investing Services